Boccadoro M, Redoglio V, Gavarotti P, Pileri A
Tumori. 1986 Apr 30;72(2):135-7. doi: 10.1177/030089168607200203.
In 19 patients with monoclonal gammopathy, plasma cell proliferative activity was evaluated using 5-bromo-2-deoxyuridine (BrdUrd) incorporation, as revealed by an anti-BrdUrd monoclonal antibody. A simultaneous standard labelled thymidine incorporation was carried out in all patients as reference test. The BrdUrd method was confirmed as a reliable test and is recommended for routine clinical application in monoclonal gammopathies.
在19例单克隆丙种球蛋白病患者中,使用5-溴-2-脱氧尿苷(BrdUrd)掺入法评估浆细胞增殖活性,通过抗BrdUrd单克隆抗体检测。所有患者同时进行标准标记的胸腺嘧啶核苷掺入作为参考试验。BrdUrd方法被确认为可靠的检测方法,推荐用于单克隆丙种球蛋白病的常规临床应用。